SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000904454-18-000039
Filing Date
2018-01-22
Accepted
2018-01-22 10:02:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCH13G/A RECEIVED IN DP ON 1-16-18 FOR JOHNSON & JOHNSON AND CATALYST BIOSCIENCE s13ga_011618-catalystbio.htm SC 13G/A 48299
  Complete submission text file 0000904454-18-000039.txt   49902
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 18538998
SIC: 2834 Pharmaceutical Preparations